White Paper

Manufacturing Drugs with Highly Potent APIs

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Altasciences, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

Manufacturing Drugs with Highly Potent APIs

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs), including:

  • a review of the relevant guidance
  • HPAPI classification systems
  • safety processes to minimize exposure risk
  • equipment and methods to prevent cross-contamination
  • how to ensure GMP compliance for regulatory submissions


Related resources from Altasciences

Supplier info centre